Lipoarabinomannan (LAM) is a major cell wall-associated lipoglycan, produced in large amounts (15 mg/g of bacteria) in different species of mycobacteria. Our laboratory has previously reported that LAM from Mycobacterium smegmatis exerts its cytotoxic activity via inhibition of protein kinase C, a key signaling molecule inside the mononuclear cells (S. Ghosh, S. Pal, S. Das, S. K. Dasgupta, and S. Majumdar, FEMS Immunol. Med. Microbiol. 21:181-188, 1998). In this study we report that LAM from Mycobacterium tuberculosis induces a signal transduction pathway in favor of survivability of the host cells via the generation of ceramide, a novel second messenger. The endogenous ceramide level in mononuclear cells was found to be enhanced during LAM treatment. The effects of LAM on protein tyrosine phosphorylation in human peripheral blood mononuclear cells were examined. LAM enhanced the tyrosine phosphorylation of p42 mitogen-activated protein kinase and phosphoinositol 3-kinase (PI3 kinase) and dephosphorylation of stress-activated protein kinase. LAM-induced phosphorylation of p42 (extracellular signal-regulated kinase 2) was further enhanced by wortmannin, a PI3 kinase inhibitor. To examine whether these effects are due to elevation of endogenous ceramide, we exposed the cells to cell-permeative C 2 -ceramide exogenously and studied the activities of different protein kinases. Fluorescence-activated cell sorter analysis and morphological studies showed that LAM induces cell survival. Therefore, these results suggest the ability of LAM to induce ceramide in the altered signaling pathway and help in cell survival.
Archeological evidence indicates that tuberculosis has afflicted humans for thousands of years (9, 39) . Mycobacterium tuberculosis, the causal organism of tuberculosis, now infects a large proportion of the population. Even now, 2 to 3 million people worldwide die each year from this disease. While tuberculosis is a preventable and largely curable disease, our understanding of the cellular and molecular interaction between mycobacteria and host immune cells is far from complete. For enhancing the antimycobacterial resistance of the host, immunization with Mycobacterium bovis (BCG) has been widely used for many years but has had little effect on reducing the incidence of tuberculosis. M. tuberculosis bacilli are noteworthy for having evolved mechanisms that allow them to survive and multiply in macrophages (49) . It was observed that the macrophages, which should actively participate to overcome the infection, become nonfunctional during pathogenesis (41) . Phagocytosis of the highly host-adapted intracellular pathogen M. tuberculosis by mononuclear phagocytes has been known as a multi-ligand-, multi-receptor-mediated event.
Lipoarabinomannan (LAM) is a cell wall-associated lipoglycan present in different species of mycobacteria, which, while remaining anchored to the mycobacterial cell membrane, is thought to extend all the way to the surface. It exhibits a wide range of immunomodulatory effects (8, 21, 23, 41) . Vesicles containing LAM are released by phagosome containing ingested mycobacteria, suggesting active transport out of infected cells (40, 52) . LAM released by infected macrophages may act in a paracrine manner to modulate the function of surrounding leukocytes. LAM alters the signaling processes in the macrophages (16) , and it has been reported that LAM inhibits M. tuberculosis-induced apoptosis (38) . Recently it has also been reported that LAM affects the signaling pathway involved in cell survival (26) . In a previous paper, we showed that there was 60 to 90% inhibition of total protein kinase C (PKC) activity in cells treated with LAM isolated from an avirulent species, Mycobacterium smegmatis (16) . However, PKC activity has also been found to be inhibited in Lamtreated cells of virulent species M. tuberculosis (8) . The effect of LAM isolated from virulent as well as avirulent strains of mycobacteria on different isotypes of PKC (both Ca dependent and Ca independent) has been studied in our laboratory. The results obtained suggest that LAM from M. tuberculosis is more potent in inhibiting the ␤-1 isotype of PKC. Also, there was enhanced expression of atypical PKC-in LAM-treated cells of M. tuberculosis, while there was inhibition in expression of PKC-when cells of M. smegmatis were treated with LAM (D. K. Roy and S. K. Majumdar, Abstr. 12th Am. Soc. Cell Biol. Meet., abstr. 404a, 2001).
As it has been observed that the classical PKC signaling pathway is inhibited in cells treated with LAM, we tried to study a signal transduction pathway other than the classical one. Ceramide is known to be an important second messenger in the altered signaling pathway (19, 28, 44) . Several components of the sphingomyelin pathway form a novel signaling pathway, which is conserved from yeast to humans (3, 12, 19, 33, 44) . Ceramide, the central molecule in this pathway, serves as the second messenger for cellular functions ranging from proliferation and differentiation to growth arrest and apoptosis (28) . Ceramide generation involves hydrolysis of sphingomyelin by sphingomyelinase or de novo synthesis by a synthase (25, 29, 44, 45) . Both neutral and acidic sphingomyelinases are transiently activated by diverse exogenous stimuli such as tumor necrosis factor alpha, gamma interferon, interleukin-1, Fas ligands, ionizing radiation, or chemotherapeutic agents, leading to an increase in the endogenous ceramide level within seconds to minutes (18, 24) . Prolonged and persistent accumulation of ceramide may also occur over a period of several hours (19) . In this paper we have shown that the endogenous cellular level of ceramide in human peripheral blood mononuclear cells (PBMC) increased when they were treated with LAM isolated from the virulent species M. tuberculosis. Ceramide interacts with several signaling systems, involving mitogen-activated protein kinase (MAPK) (30, 35) , stress activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) (7, 48) , PKC-(4, 31), and phosphatases (18) . MAPKs are activated by extracellular stimuli in many types of cells via dual phosphorylation of tyrosine and threonine kinases and are thought to be involved in various cellular responses (5, 32) . Triggering of the ceramide pathway has been implicated in the activation of SAPK/JNK, along with extracellular signal-regulated kinase (ERK) and p38 MAPK activities. We report here the LAMinduced activity of p42 MAPK (ERK 2) and the p46 JNK1 isoform of SAPK in human PBMC. However, wortmannin, an inhibitor of phosphatidylinositol 3-kinase (PI3 kinase) was also found to affect the activity of ERK 2, indicating involvement of PI3 kinase in the regulation of ERK 2. Further, we found that LAM promotes cell survival. Hence, we report that LAMinduced promotion of cell survival involves ceramide, PI3 kinase, and MAPK (ERK 2) activation.
MATERIALS AND METHODS
Purification of LAM. M. tuberculosis was isolated from the blood of affected patients at the Bengal Tuberculosis Association, Calcutta, India, and cultured on solid medium. After 3 days, it was transferred to a liquid medium named Kirchiens medium and allowed to grow at 37°C under shaking condition (30 ϫ g) for 14 days. For purification of the lipoglycan LAM from M. tuberculosis, the standard method of Hunter and Brennan (21) was used.
Blood donors. Peripheral blood was collected from adult healthy individuals of both sexes. All of them were from a middle socioeconomic background and were human immunodeficiency virus and hepatitis B virus negative.
Effector cells. PBMC were isolated by centrifugation (400 ϫ g, 40 min, 22°C) on a Ficoll-Hypaque (Sigma Diagnostics Inc.) density gradient. The cells at the interphase were collected, washed, and resuspended in RPMI 1640 culture medium (Sigma) supplemented with 10% fetal bovine serum (Gibco BRL).
Preparation of macrophage monolayer and bacteria. PBMC were isolated from healthy, purified protein derivative-negative adult volunteers and cultured in polystyrene petri dishes (Tarson) for 5 days. The macrophages were purified by adherence to these petri dishes. Effects of experimental manipulations on macrophage viability were assessed by exclusion of trypan blue. The strain of M. tuberculosis was cultured, and the concentration of bacteria was adjusted for use in the experiments after counting. Infections were at different ratios of bacteria to cells.
Preparation of whole-cell lysate of PBMC. Untreated (control) and LAM (from M. tuberculosis)-treated PBMC suspended in RPMI were cultured in 5% CO 2 at 37°C for 18 h. Following incubation, the cells were sonicated in lysis buffer and whole-cell lysates were prepared.
The cells were pelleted by centrifugation at 320 ϫ g for 10 min and resuspended in ice-cold extraction buffer containing 10 mM Tris-HCl (pH 7.5), 4.5 mM EGTA, 2.5 mM EDTA, 1.0 mM Na 3 VO 4 , and an antiprotease mixture consisting of 0.33 mM leupeptin, 0.2 mM phenylmethylsulfonyl fluoride, 4.8 trypsin inhibitor units of aprotinin ml Ϫ1 , and 50 mM 2-mercaptoethanol (Sigma). The mixture was sonicated for 5 to 10 s at 4°C. The postnuclear fraction was discarded by centrifugation at 2,800 ϫ g for 20 min.
Assay for detection and quantification of ceramide. The ceramide assay was carried out by using radiolabeled stearic acid as described by Gamen et al. (15) . Human PBMC (3 ϫ 10 6 ) were labeled for 30 h with 5 Ci of [1-14 C]stearic acid (Amersham Pharmacia Biotech) bound to acid-free serum albumin (1:1 molar ratio) in complete medium. Cells were washed with sterile HEPES to remove the unbound radioactive stearic acid, resuspended in RPMI 1640 with 10% fetal calf serum, and infected with LAM from M. tuberculosis (virulent). The cells were then incubated for different time periods as required. Total cellular lipids were extracted at 4°C with chloroform-methanol (2/1, vol/vol). The radioactivities of aliquots from CHCl 3 phases were determined by liquid scintillation counting, and equal amounts of radioactivity in each sample were applied to thin-layer chromatography Silica Gel G plates (Whatman) along with standard C 2 -and C 6 -ceramide (Sigma). The plates were air dried, and lipid bands were identified in an iodine chamber. The bands corresponding to the standard were scraped, and radioactivity was counted in an L. S. Counter (Wallac) with 4 ml of Cocktail-O (Spectrochem, Bombay, India). Gel electrophoresis and immunoblotting. Whole-cell lysates (2.5 ϫ 10 6 cells per set) were prepared in lysis buffer (10 mM Tris [pH 7.4], 4.5 mM EGTA, 2.5 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride, 1.0 mM Na 3 VO 4, 4.8 trypsin inhibitor units of aprotinin ml Ϫ1 , and 0.33 mM leupeptin). The supernatants were assayed for protein with a Bio-Rad protein assay kit. Protein samples (100 g) were analyzed by sodium dodecyl sulfate-7.5% polyacrylamide gel electrophoresis (SDS-7.5% PAGE) together with prestained molecular weight markers (Bio-Rad) and transferred to nitrocellulose as described by Majumder et al. (27) . The blots were washed in Tris-buffered saline (TBS) (50 mM Tris containing 150 mM NaCl) and blocked overnight with 3% (wt/vol) bovine serum albumin dissolved in TBS. The blots were then probed with antiphosphotyrosine antibody (1:500) (Santa Cruz Biotechnology, Santa Cruz, Calif.) according to the method of Towbin et al. (47) . The blots were next washed three times with TBS supplemented with Polysorbate T-20 (TBST) and TBS, sequentially, and incubated with anti-rabbit second antibody (Sigma) covalently linked to alkaline phosphatase. Nitroblue tetrazolium-bromochloroindolyl phosphate (Gene I) was used as the substrate for color development. The same procedure was used for anti-phospho-ERK (1:1,000) (Calbiochem) and anti-phospho-SAPK (1:1,000) (Calbiochem) immunoblotting. The blot was stripped off with a buffer containing 50 mM Tris-HCl (pH 6.7), 100 mM 2-mercaptoethanol (Sigma), and 2% SDS and incubated for 1 h at 50°C before reprobing with another type of antibody.
Staining with DAPI. Cells (3 ϫ 10 6 ), after treatment with 20 g of LAM ml
Ϫ1
and a 10 M concentration of the MEK 1 inhibitor PD 98059 (Sigma), were collected in phosphate-buffered saline (PBS), fixed with absolute alcohol, and stained with 4,6-diamidino-2-phenyl indole (DAPI), a DNA-specific dye, at a concentration of 1 g ml Ϫ1 for 1 h at room temperature. The cells were washed two times with PBS and mounted on the slides. The slides thus prepared were visualized under a microscope with a UV transmittance filter for illumination at 470 nm (50) .
Analysis of DNA fragmentation. Cells (3 ϫ 10 6 ) were treated with 20 g of LAM ml
Ϫ1 and a 10 M concentration of the MEK 1 inhibitor PD 98059 and incubated at 37°C for various time periods. Chromosomal DNA was extracted from PBMC by incubating the cells in Tris-EDTA buffer containing NP-40, RNase, and proteinase K (Boehringer Mannheim) (16) . DNA fragmentation was analyzed by 1.5% gel electrophoresis.
FACS analysis. Fluorescence-activated cell sorter (FACS) analysis of death of the mononuclear cells following different treatments was done with ethidium bromide staining. Briefly, 3 ϫ 10 6 cells per set, after the required treatment, were washed with PBS, fixed with 1% p-formaldehyde at 4°C for 30 min, and again washed with PBS twice. The cells were then incubated with 5 l of RNase A (Boehringer) in 95 l of PBS for 1 h and stained with ethidium bromide for 15 min, followed by dilution of the test solution by adding PBS buffer and evaluation by FACS (FACSCalibur; Becton Dickinson) (488-nm excitation and 515-nm long-pass filter for detection) (13) .
RESULTS
Endogenous ceramide level in LAM-treated mononuclear cells. In order to investigate whether ceramide plays any role in the signal transduction mechanism during mycobacterial infections, we treated PBMC from healthy donors with different doses of LAM and assayed for the cellular ceramide level at different time intervals. Figure 1A demonstrates the effects of different doses of LAM on the endogenous ceramide level. There were increases in the endogenous ceramide level of 25, 56, 32, and 14% after treatment with 10, 20, 30, and 40 g of LAM ml
Ϫ1 for 18 h, respectively. Taking 20 g of LAM ml Ϫ1 and about a 60% increase with 40 g of LAM ml Ϫ1 (Fig. 2A) . The detected p42 protein was found to be the ERK 2 isoform of MAPK after the blot was stripped off (46) and reprobed with anti-phospho-ERK antibody, which exhibited 40% increased activity of ERK 2 with 20 g of LAM ml
Ϫ1 and 55% increased activity with 40 g of LAM ml Ϫ1 (Fig. 2B) . However, p44 (ERK 1) was not detected at significant levels in the study.
The human macrophages were incubated with intact bacteria at different ratios. After 2 h of infection, macrophages were washed to remove the nonadherent bacilli and the cells were cultured overnight. It was observed that there was an increase in activity and expression of p42 (ERK 2) protein when immunoblotting was with anti-phospho-ERK antibody. There was increased activity of p42 (ERK 2) of about 15, 38, and 42% in the macrophages infected at ratios of 1:10, 1:20, and 1:30, respectively (Fig. 3B) .
Effect of ceramide on MAPK activity. From the experiments described above it has been found that LAM at different concentrations enhanced the endogenous ceramide level, and it had already been established that ceramide affects the other kinases in its downstream steps (7, 30, 35, 48) . Since LAM enhances the expression and activity of ERK 2, it was essential to study whether exogenous addition of ceramide mimics the same effect on ERK activity. Hence, we used cell-permeative C 2 -ceramide at different doses, exogenously. The cells were treated with 10 and 30 g of C 2 -ceramide ml Ϫ1 for 18 h and then immunoblotted with antiphosphotyrosine ( Fig. 4A ) and anti-phospho-ERK (Fig. 4B) antibodies. The results showed increased ERK 2 activity in ceramide-treated cells at 18 h. At 6 h, no such phosphorylation was noted.
Effect of LAM and ceramide on SAPK/JNK activity. The results described above prompted us to study another protein kinase, SAPK/JNK, which is known to be activated in cells undergoing apoptosis (6, 43) . Western blot analysis showed a 46-kDa band after immunoblotting with antiphosphotyrosine antibody (data not shown). We found that the p46 band coincided with the JNK1 isoform when reprobed with anti-phospho-SAPK antibody. This p46 (JNK1) isoform of SAPK/JNK was found to be inhibited when the cells were treated with 20 g of LAM ml
Ϫ1 for 18 h. There was about 10 and 30% inhibition of the activity of JNK1 with 10 and 20 g of LAM ml Ϫ1 , respectively (Fig. 5A) . However, when the cells were treated with 10 and 30 g of cell permeable C 2 -ceramide in order to obtain the SAPK/JNK activity, we found that ceramide treatment does not alter the activity of SAPK/JNK in the human mononuclear cells (Fig. 5B) . Thus, inhibition of JNK due to treatment of LAM appeared to be independent of ceramide.
When the human macrophages were infected with intact M. tuberculosis, there was also inhibition of expression and activity of p46 SAPK/JNK (Fig. 3A) Effect of wortmannin on the MAPK activity. In various cell types, PI3 kinase is implicated in regulating cell growth and inhibiting apoptosis (34, 36) , in intracellular vesicle trafficking and secretion (10, 22) , and in cytoskeletal organization (17, 37) . To elucidate the role of PI3 kinase, we examined the effect of wortmannin, a fungal metabolite and a specific inhibitor of PI3 kinase, which irreversibly inhibits p110␣ by reacting covalently with lysine 802 (36, 37, 51) . However, Western blot analysis with anti-phospho-ERK antibody demonstrated that pretreatment with 100 nM wortmannin further enhances LAM-induced p42 ERK activity in human PBMC (Fig. 6) .
LAM-induced cell survival. LAM-induced activation of
MAPK and inhibition of SAPK raised the possibility that LAM helps in cell survival. To study whether the MAPK signaling pathway mediates the LAM-induced survival of cells, we used a selective inhibitor of MEK 1 (upstream of ERK), PD 098059. FACS analysis of LAM-treated PBMC (18 h) showed a survivability peak similar to that for untreated cells (Fig. 7A, B , and C). When the cells were treated with a 10 M concentration of the MEK 1 inhibitor PD 98059 for 2 h, a moderate apoptotic peak was clearly seen (M1 region in Fig. 7D ). Pretreatment of cells with MEK 1 inhibitor for 1 h followed by LAM (20 g ml Ϫ1 ) for 18 h showed a decrease in amplitude of the apoptotic peak (M1 region in Fig. 7E ), indicating that (Fig. 8B) , similarly as seen in untreated cells (Fig.  8A ). Many apoptotic nuclei were seen in cells treated with 10 M PD 98059 for 2 h (Fig. 8C) , while the percentage of apoptosis was less in LAM-treated cells pretreated with PD 98059 (Fig. 8D) , showing that LAM induces the cells to survive via an ERK-dependent pathway. The numbers of live and apoptotic cells observed after the different treatments are shown in Table 1 .
We also carried out a DNA degradation study with control and treated cells (Fig. 9) . 
DISCUSSION
The pathogenic species M. tuberculosis has evolved strategies to undermine both acquired immune responses and innate host resistance in humans. The mechanism of pathogenesis involves the role of immunosuppressive molecules such as Table 1 . Results are from a representative experiment of three. (1, 8, 15, 42) , its mode of action is still not clear. The present study examined the possibility that LAM may alter cell signaling mechanisms in human PBMC. An altered signaling pathway in response to various stimuli often involves the production of ceramide via activation of sphingomyelinase, followed by activation of several kinases, which may ultimately lead to an apoptotic pathway (3, 20) . Therefore, our first step was to measure the endogenous intracellular level of ceramide. We found that the endogenous ceramide level is elevated in human PBMC treated with LAM of M. tuberculosis. At a concentration of 20 g of LAM ml Ϫ1 , there was transient enhancement of the endogenous ceramide level at 18 h. However, at higher concentrations, the endogenous ceramide level decreased. This may be due to the toxic effect of LAM at higher concentration (16) . Ceramide is believed to participate in signal transduction either by stimulating phosphoprotein phosphatases (18) or by activating specific serine/threonine kinases (30, 35) . One such kinase is MAPK, whose activation is known to be involved in the regulation of broad range of cellular processes (11, 32) . Our data suggest a stimulation of phosphorylation of p42 (ERK 2) MAPK in LAM-treated cells. In order to understand the role of ceramide in the phosphorylation of p42 (ERK 2), we studied the effect of exogenously added cell-permeable C 2 -ceramide at different doses on the phosphorylation of p42 and found that activity of p42 (ERK 2) increased with ceramide treatment, indicating that MAPK may be downstream of ceramide. It has been reported by a number of workers that LAM inhibits M. tuberculosis-induced apoptosis (26, 38) . Treatment with 10 M PD 98059, an inhibitor of MAPK, caused the cells to undergo apoptosis, indicating the essentiality of the ERK pathway for cell survival. The involvement and activation of SAPK/JNK in the signaling pathway has been implicated in the induction of apoptosis in a variety of systems (6, 43) . Here we observed that the phosphorylation of the p46 isoform of SAPK/JNK decreased in cells treated with LAM of M. tuberculosis, while the activity of SAPK remained somewhat unaltered when PBMC were treated with cell-permeable C 2 -ceramide exogenously. This indicates that the inhibition of p46 JNK1 was not due to the enhanced level of ceramide after 18 h of LAM treatment but may be due to the expression of LAM-induced phosphatases in the cell, as we found that the inhibition of p46 JNK in LAM-treated cells can be withdrawn by addition of okadaic acid, an inhibitor of serine/threonine phosphatase (M. Sirkar et al., unpublished data). This inhibition of SAPK/JNK is another parameter to show that LAM-induced mononuclear cells are not undergoing apoptosis. Moreover, the atypical PKC-has been shown to be expressed in LAM (virulent)-treated human mononuclear cells (Roy and Majumdar, Abstr. 12th Am. Soc. Cell Biol. Meet.). Thus, our data clearly indicate that both ceramide and LAM mediate cell proliferation, which proceeds via an ERK-dependent pathway.
PI3 kinase is implicated in the regulation of cellular growth, and its involvement in the inhibition of apoptosis is well established (14, 34, 36) . It has been reported that PI3 kinase is inhibited at a wortmannin concentration of 100 nM (2). Here we found that 100 nM wortmannin enhanced the LAM-induced p42 (ERK 2) in human mononuclear cells. Therefore, we postulate that inhibition of LAM-induced PI3 kinase involves enhancement of phosphorylation of ERK 2. This result agrees with the data in other reports that LAM stimulates Bad phosphorylation in a PI3 kinase-dependent pathway (26) .
All of these results strongly indicate that the delayed and transient increase in the endogenous ceramide level in LAMtreated PBMC modulates the protein kinases downstream. LAM of M. tuberculosis has characteristics to evoke the phosphorylation of p42 ERK, which might be regulated by PI3 kinase, while an inhibition in the activity of p46 JNK was noted. Exogenously added cell-permeative C 2 -ceramide also increased the activity of ERK, while the activity of SAPK/JNK remained unaltered at the same concentrations. Moreover, it was noted during FACS analysis and DAPI staining that PD 98059 inhibits the ERK pathway and takes the cells towards apoptosis, in contrast to the viability peak seen with LAM treatment alone. The percentage of apoptosis is considerably less in LAM-treated cells pretreated with PD 98059, a selective inhibitor of MEK 1 (upstream of ERK), in comparison to the large apoptotic nuclei seen in cells treated with PD 98059 alone. This suggests that LAM induces cell survival through the ERK pathway. Hence, LAM alters the signaling pathway and helps in increasing the survivability of the host cells, so that the pathogen could reside and multiply within the host cells. 
